Any current/future new fundraising through debt or equity?

No significant capital expenditure (capex) is planned for FY27; only routine capex of about INR 35-40 crores is expected. The company has been actively working on improving working capital by rationalizing inventory levels and reducing receivable days. There is no explicit mention of any new fundraising through debt or equity in the provided transcript content. The company repaid approximately INR 160 crores of debt in FY26, with debt-to-equity ratios of 0.30x (standalone) and 0.47x (consolidated), indicating a focus on debt reduction. Management did not indicate any plans for raising fresh eq

Any current/future capex/capital investment/strategic investment?

No significant capex planned for FY27; only routine capex of approximately INR 35-40 crores is expected. Manufacturing of new nano fertilizer products (Nano DAP, Nano NPK, Nano Zinc) will leverage existing infrastructure at Sanand facility with no additional capex. Titanium Dioxide (TiO2) plant operations are temporarily suspended due to commercial unviability; no current capex on this project. Focus on optimizing existing operations and improving working capital rather than major capital investments in the near term. Scheme of amalgamation of wholly-owned subsidiaries to consolidate operation

Future growth expectations in sales/revenue/volumes?

Significant top-line growth expected over the next 3 to 5 years, driven mainly by the Crop Protection segment with double-digit growth. Crop Nutrition segment to see reasonable growth supported by nano fertilizer products like Nano Urea, Nano DAP, Nano NPK, and Nano Zinc. Continuous and growing demand for nano-based fertilizers due to fertilizer availability issues and government promotion. Pigments segment expected to have flat to moderate revenue growth (INR 500-600 crores range) with improving profitability from cost optimization. Overall, FY27 revenue and profitability expected to improve

Future growth expectations in earnings/operating earnings/profits/EPS?

Management expects significant top-line and bottom-line growth over the next 3 to 5 years, driven primarily by the Crop Protection and Crop Nutrition segments. Crop Protection segment is anticipated to achieve double-digit revenue growth with EBITDA margins in the range of 15% to 17% in FY27 and beyond. Crop Nutrition segment (including nano-based fertilizers like Nano Urea, Nano DAP, Nano NPK) is expected to see substantial growth and improved profitability due to increasing farmer adoption amid fertilizer availability issues. Pigments segment is projected to maintain stable revenues (I

Current/ Expected Orderbook/ Pending Orders?

Meghmani Organics currently has some orders for Nano Urea in the pipeline. More orders are expected going forward, indicating a growing demand. Orders will reflect in revenues on a quarter-on-quarter basis, varying by market and season. Revenue growth from these orders is anticipated across all quarters within the financial year. The management expects significant growth in both top line and bottom line from the Crop Nutrition segment, including Nano Urea and other nano-based fertilizers. No specific quantification of pending orders or orderbook size was provided. The outlook is positive, with

IN US

Sale is live|00:00:00left today

Meghmani Organics LtdQ1 FY26Fertilizers & Agrochemicals

Meghmani Organics Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹47.7P/E: 46.1Market Cap: ₹1.3K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

Yes

Capex

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→Significant top-line growth expected over the next 3 to 5 years, driven mainly by the Crop Protection segment with double-digit growth.
→Crop Nutrition segment to see reasonable growth supported by nano fertilizer products like Nano Urea, Nano DAP, Nano NPK, and Nano Zinc.
→Continuous and growing demand for nano-based fertilizers due to fertilizer availability issues and government promotion.
→Pigments segment expected to have flat to moderate revenue growth (INR 500-600 crores range) with improving profitability from cost optimization.
→Overall, FY27 revenue and profitability expected to improve compared to FY26.
→No specific quarter-wise projections, but steady growth anticipated across quarters depending on market seasons.
→Long-term EBITDA margin guidance for Crop Protection maintained at 15%-17%.

Margin guidance

Category 2

→Management expects significant top-line and bottom-line growth over the next 3 to 5 years, driven primarily by the Crop Protection and Crop Nutrition segments.
→Crop Protection segment is anticipated to achieve double-digit revenue growth with EBITDA margins in the range of 15% to 17% in FY27 and beyond.
→Crop Nutrition segment (including nano-based fertilizers like Nano Urea, Nano DAP, Nano NPK) is expected to see substantial growth and improved profitability due to increasing farmer adoption amid fertilizer availability issues.
→Pigments segment is projected to maintain stable revenues (INR 500-600 crores) with improved profitability through cost optimizations.
→Overall profitability and EBITDA margins are expected to improve compared to previous challenging years, supported by price rationalization and operational efficiencies.
→Management acknowledges recent difficult years but remains confident in long-term value creation and has plans to resume dividend payouts in FY27 reflecting better financial performance.

3 more insights locked — sign up free to unlock

Fundraise plans

→No significant capital expenditure (capex) is planned for FY27; only routine capex of about INR 35-40 crores is expected.
→The company has been actively working on improving working capital by rationalizing inventory levels and reducing receivable days.
→There is no explicit mention of any new fundraising through debt or equity in the provided transcript content.
→The company repaid approximately INR 160 crores of debt in FY26, with debt-to-equity ratios of 0.30x (standalone) and 0.47x (consolidated), indicating a focus on debt reduction.
→Management did not indicate any plans for raising fresh equity or significant new debt during the FY27 period.

Order book

Yes

→Meghmani Organics currently has some orders for Nano Urea in the pipeline.
→More orders are expected going forward, indicating a growing demand.
→Orders will reflect in revenues on a quarter-on-quarter basis, varying by market and season.
→Revenue growth from these orders is anticipated across all quarters within the financial year.
→The management expects significant growth in both top line and bottom line from the Crop Nutrition segment, including Nano Urea and other nano-based fertilizers.
→No specific quantification of pending orders or orderbook size was provided.
→The outlook is positive, with continuous and increasing demand expected due to fertilizer availability issues and farmer adoption of nano-based fertilizers.

Capex plans

→No significant capex planned for FY27; only routine capex of approximately INR 35-40 crores is expected.
→Manufacturing of new nano fertilizer products (Nano DAP, Nano NPK, Nano Zinc) will leverage existing infrastructure at Sanand facility with no additional capex.
→Titanium Dioxide (TiO2) plant operations are temporarily suspended due to commercial unviability; no current capex on this project.
→Focus on optimizing existing operations and improving working capital rather than major capital investments in the near term.
→Scheme of amalgamation of wholly-owned subsidiaries to consolidate operations and achieve operational and financial synergies, not direct capex but strategic restructuring for resource optimization.

How does Meghmani Organics Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Meghmani Organics Ltd

Rev 3Mar 2

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Meghmani Organics Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio